A Combined Approach of Neoadjuvant Chemotherapy and Surgery for Colorectal Liver Metastases

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 4 SUPPL., 2003, Pages 197-202

  Esposito, A ^a   Mancini, R ^a   Ettorre, G ^a   Garufi, C ^a   Saracca, E ^a   Arcieri, S ^b   Cosimelli, Maurizio ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Colorectal liver metastases; Cryosurgery; Neoadjuvant chemotherapy; Radiothermal ablation; Surgical resection

Indexed keywords

ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER RECURRENCE; COLON CANCER; COLORECTAL CANCER; CONFERENCE PAPER; CRYOSURGERY; FOLLOW UP; HUMAN; LIVER FAILURE; LIVER METASTASIS; LYMPH NODE METASTASIS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY RADIATION; RECTUM CANCER; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA; CATHETER ABLATION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CRYOSURGERY; HUMANS; LIVER NEOPLASMS; NEOADJUVANT THERAPY; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 1842582540     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (72)

1. Parikh AA, Curley SA, Fomage BD, Ellis LM. Radiofrequency ablation of hepatic metastases. Semin Oncol. 2002 Apr;29(2):168-82.
2. Kohnoe S, Endo K, Yamamoto M, et al. Protracted hepatic arterial infusion with low-dose cisplatin plus 5-fluorouracil for unresectable liver metastases from colorectal cancer. Surgery. 2002 Jan;131(1 Suppl):S128-34.
3. Seidenfeld J, Korn A, Aronson N. Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg. 2002 Sep;195(3):378-86.
4. Greenlee RT, Murray T, Bolden S, et al. Cancer statistic, 2000. CA Cancer J Clin 2000;50:7-33.
5. Talamonti MS., Tellez C., Benson AB 3rd. Local-regional Therapy for metastatic liver tumors. Cancer Treat Res 1998;98:172-99.
6. Choti MA., Bulkley GB. Management of hepatic metastases. Liver Transplant Surg 1999;5:65-80.
7. Miller CA., Ellison ECD. Therapeutic alternatives in metastatic neoruendocrine tumors. Surg Oncol Clin North Am 1998;7:863-79.
8. Adams R., Avisar E., Ariche A., et al. Five-years survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal metastases. Ann Surg Oncol 2001;8(4):347-53.
9. Patel NH., Jindal RM. The role of chemoembolization in the treatment of colorectal hepatic metastases. Hepato-Gastroenterology 2001;48:448-52.
10. Onaitis M., Morse M., Hurwitz H. Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 2003;6:782-9.
11. Bengmark S., Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. Cancer 1969;23:198-2002.
12. Cosimelli M., Anzà M., Arena MG., et al. Growth time and metastatic potential of the 3924. A Morris hepatoma implanted in rat liver: experimental model of a single tumor. J Exp Clin Cancer Res 1992;11:123-132.
13. Cosimelli M., Di Tora P., Casaldi V., et al. Hepatic arterial infusion chemotherapy for unresectable colorectal liver metastases: a twelve-year experience. J Exp Clin Cancer Res 1995;14:41-51.
14. Fiorentini G., Basilio Poddie D., Cantore M. Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities. Hepato-Gastroenterology 2001;48:305-15.
15. Scheele J., Stangl R., Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on natural history. Br J Surg 1990;77:1241-6.
16. Ruers TJM., Joosten J., Jager GJ., Wobbes T. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 2001;88:844-9.
17. Weiss L., Grundmann E., Torhorst J., et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986;150:195-203.
18. Bengtsson G., Carlsson g., Hafstrom L., et al. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981;141:586-9.
19. Jaffe BM., Donegan WL., Watson F., et al. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968;
20. Wagner JS., Adson MA., van Heerden JA., et al. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984;199:502-8.
21. Wood CB., Gills CR., Blumgart LH. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976;2:285-8.
22. Chung MH., Ye W., Ramming KP., Bilchik AF. Repeat hepatic cryotherapy for metastatic colorectal cancer. J Gastrointest Surg 2001;5:287-93.
23. Fong Y., Blumgart L., Cohen A., Fortner J., Brennan M. Repeat hepatic resection for metastatic colorectal cancer. Ann Surg 1994;220:657-62.
24. Dizon DS., Kemeny NE. Intrahepatic arterial infusion of chemotherapy: clinical results. Semin Oncol 2002;29:126-35.
25. Tono T., Hasuike Y., Orzato H., Takatsuka Y., Kikkawa N. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Cancer 2000;88:1549-56.
26. Gayowsky TJ., Iwatsuki S., Manariaga J., et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994;116:703-11.
27. Ballantyne GH., Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993;71:4252-66.
28. Steele GJ., Ravikumar TS. Resection of hepatic metastases from colorectal cancer: biologic perspective. Ann Surg 1989;210:127-38.
29. Meric F., Patt YZ., Curley SA. Surgery after a downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 200;7:490-5.
30. McCarty TM., Kuhm JA. Cryotherapy for liver tumors. Oncology 1998;12:979-87.
31. Scudamore CH., Lee SI., Patterson EJ. Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg 1999;177:411-7.
32. Welch J., Donaldson G. The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 1978;189:496-502.
33. Adams R. Chemotherapy and surgery: new perspective on the treatment of unresectable liver metastases. Ann Oncol 2003;14(2):ii13-ii16.
34. Jaeck D., Bachellier P., Nakano H., et al. One or Two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 2003;185:221-9.
35. Elias D., Ouellet J-F., de Baère T., Lasser P., Roche A. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 2002;131:294-9.
36. Azoulay D., Casting D. Smail A., et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000;231:480-6.
37. Fong Y., Fortner JG., Sun RL., et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer. Ann Surg 1999;230:309-21.
38. Minigawa M., Makuuchi M., Torzilli G., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000;231:487-99.
39. Ambiru S., Miyazaki M., Isono T., et al. Hepatic resection for colorectal metastases: analysis of prognostic factors.
40. Tanaka K., Adam R., Shimada H., et al. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 2003;90:963-9.
41. Pinson C., Wright J., Chapman W., et al. Repeat hepatic surgery for colorectal cancer metastatic to the liver. Ann Surg 1996;223:765-76.
42. Kin T., Nakajima Y., Kanehiro H., et al. Repeat hepatectomy for recurrent colorectal metastases. World J Surg 1998;22:1087-91.
43. Kianmanesh R., Farges O., Abdalla EK., et al. Right portal vein legation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 2003;197:164-70.
44. Mathur P., Allen-Mersh TG. Hepatic arterial chemotherapy for colorectal liver metastases. Hepato-Gastroenterology 2001;48:317-9.
45. Fong Y., Cohen Am., Forter JG., et al. Liver resection for colorectal metastases. J Clin Oncol 1997;15:938-46.
46. Scheele J., Stang R., Altendorf-Hofmann A., Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
47. Jenkins LT., Millikan KW., Bines SD., Staren ED., Doolas A. Hepatic resection for metastatic colorectal cancer. Am Surg 1997;63:605-10.
48. Cady B, Jenkins RL, Steele GDJ., et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998;227:566-71.
49. Weber SM., Jarnagin WR., DeMatteo RP., Blumgart LH., Fong Y. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000;7:643-50.
50. Bolton JS., Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000;231:743-51.
51. Kokudo N., Tada K., Seki M., et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001;34:267-72.
52. Sugawara Y., Yamamoto J., Yamasaki S., et al. Estimating the prognosis of hepatic resection in patients with metastatic liver tumors from colorectal cancer with special concern for the timing of hepatectomy. Surgery 2001;129:408-13.
53. Blumgart LH. Curative and palliative therapy of liver metastases. Kongressbd Dtsch Ges Chir Kongr 2002;119:76-8.
54. de Santibanes E., Lassalle FB., McCormack L., et al. Simultaneous colorectal and hepatic resections for colorectal cancer: postoperative and long-term outcomes. J Am Coll Surg 2002;195:196-202.
55. Nagakura S., Shirai Y., Yokoyama N., et al. Major hepatic resection reduces the probability of intrahepatic recurrences following resection of colorectal carcinoma liver metastases. Hepato-Gastroenterology 2003;50:779-83.
56. Schmidt J., Strotzer M., Fraunhofer S., Boedeker H., Zirngibl H. Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis. World J Surg 2000;24:43-7.
57. Bloed W., van Leeuwen MS., Borel Rinkes IH. Role of intraoperative ultrasound of the liver with improved preoperative hepatic imaging. Eur J Surg 2000;166:691-5.
58. Jarnagin WR., Bach AM., Winston CB., et al. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg 2001;192:577-83.
59. Bismuth H., Adams R., Lévi F., et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-22.
60. Shankar A., Leonard P., Renaut AJ., et al. Neo-adjuvant therapy improves resecability rates for colorectal liver metastases. Ann R Coll Surg Engl 2001;83:85-8.
61. Gayral F., Edouard D., Bedossa P., et al. Response to hepatic intra-arterial chemotherapy for metastases of colorectal cancer. Anatomo-pathological evaluation apropos of 3 cases of secondary hepatic excision. Gastroenterol Clin Biol 1987;11:88-92.
62. Wadler S., Schwartz EL., Goldman M., et al. Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol 1989;7:1769-75.
63. Fowler WC., Eisenberg BL., Hoffman JP. Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma. J Surg Oncol 1992;51:122-5.
64. Giacchetti S., Itzhaki M., Gruia G., et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663-9.
65. Akasu T., Moriya Y., Takayama T. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization. Jpn J Clin Oncol 1997;27:331-5.
66. Lorentz M., Mueller HH., Mattes E., et al. Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas. Ann Oncol 2001;12:321-5.
67. Gillams AR., Lees WR. Survival after percutaneous, image-guided, Thermal ablation of Hepatic metastases from colorectal cancer. Dis Colon Rectum 2000;43:656-61.
68. Rossi S., Buscarini E., Garbagnati F. et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. A J Roentgenol 1998;170:1015-22.
69. Solbiati L., Ierace T., Goldberg SN., et al. Percutaneous US-guided RF tissue ablation of liver metastases: results of treatment and follow-up in 16 patients. Radiology 1997;202:195-203.
70. Livraghi T., Goldberg SN., Monti F., et al. Saline-enhanced radiofrequency tissue ablation in the treatment of the liver metastases. Radiology 1997;2002:205-10.
71. Lencioni R., Goletti O., Armillotta N., et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998;8:1205-11.
72. Jiao LR., Hansen PD., Havlik R., et al. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors. Am J Surg 1999;177:303-6.